Arts Clínic, Valencia, Spain.
i2e3 Biomedical Research Institute, Santa Coloma de Gramenet, Spain.
Skin Res Technol. 2023 Jul;29(7):e13412. doi: 10.1111/srt.13412.
To evaluate the efficacy and safety of photothermal bioactivated platelet-rich plasma for reducing laxity in facial rejuvenation in patients not eligible for other aesthetic treatments due to several comorbidities.
A prospective, nonrandomized study was conducted. Efficacy was assessed through a satisfaction scale and the Facial Laxity Rating Scale. Safety assessments were based on the data of all adverse events and the visual analog pain scale.
Seven patients with a mean age of 51 (standard deviation [SD] 7.46, range 42-63) were included. In six patients (85.7%), the treatment was applied to the face and neck, and in one patient (14.3%), only to the lower half of the face and neck. The physician's perception of laxity decreased, and the procedure was not complex. Patients' and physician satisfaction increased as the study progressed. Adverse effects were not serious and resolved without sequelae. The patients' pain perceived during the treatment was mild in most cases.
The photothermal bioactivated platelet-rich plasma injections were a safe and effective treatment for facial laxity in patients not eligible for other procedures, providing good satisfaction.
评估光热生物激活富血小板血浆减少因多种合并症而不适合其他美容治疗的患者面部年轻化松弛的疗效和安全性。
进行了一项前瞻性、非随机研究。通过满意度量表和面部松弛评分量表评估疗效。安全性评估基于所有不良事件的数据和视觉模拟疼痛量表。
共纳入 7 名平均年龄为 51 岁（标准差 [SD] 7.46，范围 42-63）的患者。6 名患者（85.7%）接受了面部和颈部治疗，1 名患者（14.3%）仅接受了下半部面部和颈部治疗。医生对松弛的感知降低，且该过程并不复杂。随着研究的进展，患者和医生的满意度增加。不良反应并不严重，且无后遗症。大多数情况下，患者在治疗过程中感知到的疼痛较轻。
对于不适合其他治疗的患者，光热生物激活富血小板血浆注射是一种安全有效的面部松弛治疗方法，可获得良好的满意度。
